PharmAust reappoints MD and resets its sights on MND battle
Biotechnical company PharmAust has reappointed Dr Michael Thurn as Managing Director and and Dr Nicky Wallis as Chief Scientific Officer.
The Watchlist
Previous Video
Next Video
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online